Navigation Links
Champions Biotechnology Partners with Do-Coop Technologies to Advance Its Novel Oncology Compound Into Biomerk Tumorgraft(TM) Testing
Date:7/16/2009

BALTIMORE, July 16 /PRNewswire-FirstCall/ -- Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR), a company engaged in the development of advanced preclinical platforms and tumor specific data to enhance the value of oncology drugs, has established a collaboration with Do-Coop Technologies Ltd. of Israel for development of a more soluble form of SG410, its Benzoylphenylurea (BPU) sulfur analog compound. SG410, an in-licensed compound, is the first agent in Champions' drug development pipeline. Using Neowater((R)), a novel proprietary water-based nanotechnology, Do-Coop has been able to improve the solubility and activity of SG410.

SG410 is an antimitotic inhibitor that was shown in Biomerk Tumorgraft models to target microtubule associated protein tau (MAPT) deficient tumors with promising results as compared to a currently marketed and leading chemotherapeutic drug. These antimitotic inhibitors target MAPT (Microtubule-Associated Protein Tau) deficient tumors. In both in vitro and in vivo models, SG410 has demonstrated promising activity against prostate and pancreatic cancer.

"We are excited to work with this innovative technology that enables us to move SG410 into Biomerk Tumorgraft testing and determine its optimal clinical application," said Doug Burkett, Ph.D., President of Champions Biotechnology, Inc. "We expect to have early Biomerk Tumorgraft results for SG410 by the end of 2009. Also, following nearly a year of efforts to build our oncology drug pipeline we expect to in-license additional drugs in the near future; SG410 is anticipated to be the first of many in-licensed compounds to enter Biomerk Tumorgraft evaluation. Our Biomerk Tumorgraft technology enables identification of the most promising development path for the compound in terms of indication, drug combination, and target patient populations
'/>"/>

SOURCE Champions Biotechnology, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Champions Biotechnology, Inc. Establishes UK Subsidiary and Retains General Manager to Expand Its Personalized Oncology Business
2. Champions Biotechnology Reports Fiscal 2009 Third Quarter Financial Results
3. Champions Biotechnology Reports Fiscal 2008 Full-Year Financial Results
4. Champions Biotechnology and ImClone Systems Establish Agreement for Preclinical Evaluation of Oncology Drugs
5. Champions Biotechnology, Inc. Completes $2,500,000 Private Financing at $1.75 per Share
6. Champions Biotechnology, Inc. Appoints New Board Members and Forms Management Team
7. Ferring Pharmaceuticals Announces EUFLEXXA(TM) as Title Sponsor of the National Senior Games Hockey Championships and the GeezerJock of the Year Award
8. Dr. David Sidransky Appointed Chairman of Champions Biotechnology, Inc.
9. Finesse Solutions Forges Agreement With Leading Biotechnology Company for Single-Use Technology Exploration
10. German Alliance for Industrial Biotechnology Debuts in Montreal
11. Johnson & Johnson Completes Acquisition of Cougar Biotechnology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... 2014 GMO corn cases filed across ... are in the process of being consolidated in a ... is In Re: Syngenta AG MIR 162 Corn Litigation, ... the District of Kansas. , Management of the Syngenta ... to U.S. District Judge John W. Lungstrum.* , As ...
(Date:12/24/2014)... MD (PRWEB) December 23, 2014 ... into law H.R. 83, the Omnibus and Continuing ... first time, made hydrocephalus a condition eligible to ... Programs (CDMRP) administered by the Department of Defense ... with its allies on Capitol Hill, is celebrating ...
(Date:12/24/2014)... Nashville, Tenn. (PRWEB) December 23, 2014 ... Hill was elected treasurer for the American Society ... to advancing knowledge and research in reproductive medicine. ... fills a seat on the executive board and will ... , Dr. Hill has actively supported ASRM since ...
(Date:12/24/2014)... -- China Biologic Products, Inc. (NASDAQ: CBPO, "China ... plasma-based biopharmaceutical company in China ... Taibang Biological Products Co. Ltd., has received Good ... and Drug Administration (the "CFDA") for its new ... the Company,s public filings, the CFDA inspected this ...
Breaking Biology Technology:Carey Danis & Lowe Reports on Syngenta GMO Corn Transfer Order 2Rare Brain Condition Now Eligible for Department of Defense Research Dollars 2Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 2Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 3China Biologic Receives GMP Certification for New Coagulation Factor Facility 2China Biologic Receives GMP Certification for New Coagulation Factor Facility 3
... NEW YORK, Nov. 4 Wall St. Network,s 3-Minute,Press ... Tracee Tolentino that,features in-depth interviews with public company executives ... show is designed to provide viewers with insight into ... growth., Shows air Monday through ...
... Nov. 4 Uroplasty, Inc. (Amex:,UPI) announced today that ... Healthcare Conference on Monday, November 10, 2008 at the ... President and Chief Executive,Officer and Medi Jiwani, Vice President ... and historical financial,performance at 4:55 p.m. Eastern Time., ...
... 4 ADVENTRX Pharmaceuticals,Inc. (Amex: ANX ) today ... is scheduled to present at the Rodman & Renshaw,10th ... present,on Tuesday, November 11th, 2008 at 2:50 p.m. Eastern ... 10-12, 2008 at the,Palace Hotel in New York., ...
Cached Biology Technology:[video] Wall St. Network's 3-Minute Press Show Features Executive Interviews and Highlights Recent Press for the Following: GTHR, BHRT, AGO 2Uroplasty to Present at the Rodman & Renshaw 10th Annual Healthcare Conference in New York 2
(Date:12/11/2014)... , Dec. 10, 2014  That blood pressure plays ... a while. Hypertension – the medical term for high blood ... early 1800s, and the inflatable cuff that,s used in measuring ... however, mean there,s nothing new about hypertension, its triggers and ... beliefs about the condition and the best ways to treat ...
(Date:12/10/2014)... Dec. 8, 2014 You,ve been here before: you ... can,t remember your password, site key or the answer to ... first grade teacher? Today, Hoyos Labs ... app that will finally put an end to the frustration ... TM . 1U leverages a user,s smartphone to acquire ...
(Date:12/10/2014)... , Dec. 9, 2014  Wake Forest Baptist Medical ... building for its School of Medicine. Funding for this ... capital campaign that will be publicly launched next summer. ... located in the former 60 series R.J. Reynolds Tobacco ... Quarter. Construction will begin immediately with plans to be ...
Breaking Biology News(10 mins):Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4
... Diego, Calif. For snakes, spiders, and other venomous creatures, ... the area on the surface of a protein that is ... constraints, say researchers from Ben Gurion University in Israel. Understanding ... unstudied toxins will do damage, and may also aid in ...
... of Toronto Scarborough (UTSC) researcher is examining how environmental ... Fatigue Syndrome. The research could lead to better insights ... Patrick O. McGowan, professor in the department of biological ... is looking at how environmentally triggered changes to gene ...
... personal tragedy of chronic alcoholism there is heartbreak in ... the heart and that mitochondria, the cellular energy factories, ... the precise mechanism. Now new experiments led by ... York State Department of Health in Albany, and Thomas ...
Cached Biology News:Molding the business end of neurotoxins 2Research examines environmental triggers altering gene function in CFS patients 2A change of heart 2
... - Fixation medium Reagent B - Permeabilisation ... fixing cells in suspension with Reagent A ... B. This procedure gives antibodies access to ... characteristics of the cells intact. Specific formulations ...
... Solution, High pH This pH 9.9 ... prior to immunohistochemical staining procedures. It is ... mounted on glass slides. For particular antigens, ... especially effective. It should be noted that ...
... Target Retrieval Solution, High pH, Concentrated x ... intended for heat-induced target retrievel prior to ... on formalin-fixed, paraffin-embedded tissue sections mounted on ... at high pH, 9.9, is especially effective. ...
... BioLogic Maximizer kit, 110 to 220 ... monitoring and doubles flow rates and ... systems. The kit includes the Maximizer ... starter kit, tubing kit, system cable ...
Biology Products: